CA3249979A1 - Composé et son utilisation - Google Patents

Composé et son utilisation

Info

Publication number
CA3249979A1
CA3249979A1 CA3249979A CA3249979A CA3249979A1 CA 3249979 A1 CA3249979 A1 CA 3249979A1 CA 3249979 A CA3249979 A CA 3249979A CA 3249979 A CA3249979 A CA 3249979A CA 3249979 A1 CA3249979 A1 CA 3249979A1
Authority
CA
Canada
Prior art keywords
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3249979A
Other languages
English (en)
Inventor
Zhiguang Zhang
Guitao WANG
Fei SHA
Liuliu Yan
Zhigang Wei
Gang Qian
Shanjun Jiang
Baohua Robert HUANG
Lianyong Chen
Original Assignee
Coherent Biopharma Suzhou Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coherent Biopharma Suzhou Ltd filed Critical Coherent Biopharma Suzhou Ltd
Publication of CA3249979A1 publication Critical patent/CA3249979A1/fr
Pending legal-status Critical Current

Links

CA3249979A 2022-04-20 2023-04-20 Composé et son utilisation Pending CA3249979A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNPCT/CN2022/088021 2022-04-20
CNPCT/CN2022/136395 2022-12-02
CN202310361865.X 2023-04-06

Publications (1)

Publication Number Publication Date
CA3249979A1 true CA3249979A1 (fr) 2026-03-01

Family

ID=

Similar Documents

Publication Publication Date Title
EP4101852A4 (fr) Composé de pyridopyrimidinone et son utilisation
EP4105211A4 (fr) Composés pyrimidohétérocycliques et leur application
EP4096651A4 (fr) Composés et leurs utilisations
EP4096668A4 (fr) Composés et leurs utilisations
EP4096664A4 (fr) Composés et leurs utilisations
EP4247815A4 (fr) Composés et leurs utilisations
EP4151636A4 (fr) Composé pyrrolidine et son utilisation
AU2022300316A1 (en) Novel compounds and their use
EP4337211A4 (fr) Composés et leurs utilisations
CA3295659A1 (fr) Composé et son utilisation
HK40130291A (en) Compound and use thereof
CA3249979A1 (fr) Composé et son utilisation
HK40117316A (en) Compound and use thereof
HK40102139A (en) Heteroaryl-3-piperidinedione compound and use thereof
AU2021219489A1 (en) Compound and use thereof
CA3269972A1 (fr) Composés et leur utilisation
AU2024357784A1 (en) Compounds and uses thereof
CA3307870A1 (fr) Composés et leurs utilisations
CA3291811A1 (fr) Composés et leurs utilisations
CA3270830A1 (fr) Composés et leurs utilisations
HK40123856A (en) Compounds and uses thereof
CA3301202A1 (fr) Composés et utilisations
CA3292331A1 (en) New micropeptide hmbj and use thereof
HK40114381A (en) Macromolecule-supported 8-sulfonyl-benzazepine compounds and their uses
HK40122959A (en) Nitrogen-containing compound and use thereof